journal article·2010-09-22

Enhanced Uptake of Porous Silica Microparticles by Bifunctional Surface Modification with a Targeting Antibody and a Biocompatible Polymer

Kai Cheng, Steven R. Blumen, Maximilian B. MacPherson, Jeremy L. Steinbacher, Brooke T. Mossman, Christopher C. Landry

Publisher page

Abstract

Strategies were developed by which mesoporous microparticles were modified on their external surfaces with tetraethylene glycol (TEG), a protein, or both, leaving the pore surfaces available for modification with a separate moiety, such as a dye. Only particles bifunctionally modified with both TEG and a cell-specific antibody were taken up specifically by a targeted cancer cell line. In contrast to similarly functionalized nanoparticles, endocytosed microparticles were not contained within a lysosome.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Advanced biosensing and bioanalysis techniques · Diatoms and Algae Research · Polymer Surface Interaction Studies

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Departments of Chemistry and Pathology, University of Vermont, Burlington, Vermont 05405

References (48)

Show source-provided references
1. Gref R. · Science · 1994 · 263 · 160010.1126/science.8128245 ↗
2. Harris J. M. · Nat. Rev. Drug Discovery · 2003 · 2 · 21410.1038/nrd1033 ↗
3. Gabizon A. · Clin. Pharmacokinet. · 2003 · 42 · 41910.2165/00003088-200342050-00002 ↗
4. Liong M. · ACS Nano · 2008 · 2 · 88910.1021/nn800072t ↗
5. Saul J. M. · J. Controlled Release · 2003 · 92 · 4910.1016/S0168-3659(03)00295-5 ↗
6. Maruyama K. · Biochim. Biophys. Acta, Biomembr. · 1995 · 1234 · 7410.1016/0005-2736(94)00263-O ↗
7. Nobs L. · J. Pharm. Sci. · 2004 · 93 · 198010.1002/jps.20098 ↗
8. Gu F. X. · Nano Today · 2007 · 2 · 14
9. Murphy E. A. · Proc. Natl. Acad. Sci. U.S.A. · 2008 · 105 · 934310.1073/pnas.0803728105 ↗
10. Kikkeri R. · J. Am. Chem. Soc. · 2009 · 131 · 211010.1021/ja807711w ↗
11. Akerman M. E. · Proc. Natl. Acad. Sci. U.S.A. · 2002 · 99 · 1261710.1073/pnas.152463399 ↗
12. de Juan F. · Adv. Mater. · 2000 · 12 · 43010.1002/(SICI)1521-4095(200003)12:6<430::AID-ADMA430>3.0.CO;2-3 ↗
13. Cheng K. · J. Am. Chem. Soc. · 2007 · 129 · 967410.1021/ja070598b ↗
14. Shephard D. S. · Angew. Chem., Int. Ed. · 1998 · 37 · 271910.1002/(SICI)1521-3773(19981016)37:19<2719::AID-ANIE2719>3.0.CO;2-6 ↗
15. Cauda V. · J. Am. Chem. Soc. · 2009 · 131 · 1136110.1021/ja809346n ↗
16. Gartmann N. · Angew. Chem., Int. Ed. · 2009 · 48 · 635410.1002/anie.200902436 ↗
17. Kecht J. · Chem. Mater. · 2008 · 20 · 720710.1021/cm801484r ↗
18. De M. · Adv. Mater. · 2008 · 20 · 422510.1002/adma.200703183 ↗
19. Rosi N. L. · Chem. Rev. · 2005 · 105 · 154710.1021/cr030067f ↗
20. Lewinski N. · Small · 2008 · 4 · 2610.1002/smll.200700595 ↗
21. Fitzpatrick J. A. J. · Nano Lett · 2009 · 9 · 273610.1021/nl901534q ↗
22. Oberdorster G. · Nanotoxicology · 2007 · 1 · 210.1080/17435390701314761 ↗
23. Handy R. D. · Ecotoxicology · 2008 · 17 · 31510.1007/s10646-008-0206-0 ↗
24. Gallis K. W. · Adv. Mater. · 1999 · 11 · 145210.1002/(SICI)1521-4095(199912)11:17<1452::AID-ADMA1452>3.0.CO;2-R ↗
25. Gallis, K. W. and Landry, C. C.United States Patent 6 334 988 2002.
26. Nassivera T. · J. Chromatogr. A · 2002 · 973 · 9710.1016/S0021-9673(02)01200-1 ↗
27. Nassivera, T. W. and Landry, C. C.United States Patent Application 2006118490.
28. Pekarek K. J. · Nature · 1994 · 367 · 25810.1038/367258a0 ↗
29. Anderson J. M. · Adv. Drug Delivery Rev. · 1997 · 28 · 510.1016/S0169-409X(97)00048-3 ↗
30. Kogan F. M. · Environ. Health Perspect. · 1994 · 102 · 205
31. Williams A. O. · Hepatology · 1996 · 23 · 1268
32. Mossman B. T. · Am. J. Respir. Crit. Care Med. · 1998 · 157 · 166610.1164/ajrccm.157.5.9707141 ↗
33. Johnston C. J. · Toxicol. Sci. · 2000 · 56 · 40510.1093/toxsci/56.2.405 ↗
34. Warheit D. B. · J. Environ. Pathol. Toxicol. Oncol. · 2001 · 1 · 133
35. Kim J. S. · Toxicol. Sci. · 2006 · 89 · 33810.1093/toxsci/kfj027 ↗
36. Tan K. · Gene Ther. · 2007 · 14 · 82810.1038/sj.gt.3302937 ↗
37. Vallet-Regi M. · Angew. Chem., Int. Ed. · 2007 · 46 · 754810.1002/anie.200604488 ↗
38. Slowing I. I. · Adv. Drug Delivery Rev. · 2008 · 60 · 127810.1016/j.addr.2008.03.012 ↗
39. Blumen S. R. · Am. J. Respir. Cell Mol. Biol. · 2007 · 36 · 33310.1165/rcmb.2006-0319OC ↗
40. Hillegass, J. M., Blumen, S. R., Cheng, K., MacPherson, M. B., Aleexeva, V., Lathrop, S. A., Beuschel, S. L., Steinbacher, J. L., Butnor, K. J., Ramos-Nino, M. E., Shukla, A., James, T. A., Weiss, D. J., Taatjes, D. J., Landry, C. C., and Mossman, B. T.Int. J. Cancer2010, in revision.
41. Ohara C. J. · Am. J. Pathol. · 1990 · 136 · 421
42. Stöber W. · J. Colloid Interface Sci. · 1968 · 26 · 6210.1016/0021-9797(68)90272-5 ↗
43. Hassan R. · Clin. Cancer Res. · 2004 · 10 · 393710.1158/1078-0432.CCR-03-0801 ↗
44. Saad M. · J. Controlled Release · 2008 · 130 · 10710.1016/j.jconrel.2008.05.024 ↗
45. Cao Z. H. · Angew. Chem., Int. Ed. · 2009 · 48 · 649410.1002/anie.200901452 ↗
46. Rosenholm J. M. · ACS Nano · 2009 · 3 · 19710.1021/nn800781r ↗
47. Mok H. · Langmuir · 2009 · 25 · 164510.1021/la803542v ↗
48. Tong G. J. · J. Am. Chem. Soc. · 2009 · 131 · 1117410.1021/ja903857f ↗